Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medical errors on the agenda at FDA/AHRQ (Agency for Healthcare Research and Quality) meeting

This article was originally published in Clinica

Executive Summary

The US FDA and the Agency for Healthcare Research and Quality are sponsoring a two-day public workshop on avoiding errors in transfusion medicine. Issues to be addressed on the first day of the workshop include: patient and medication identification; errors in manufacturing and testing of blood and blood components, system errors and cultural factors and the role of product deviation reporting in reducing transfusion errors. The second day will focus on current and future technology trends that should help prevent transfusion errors.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064566

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel